Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02588248 · ClinicalTrials.gov registry record · Phase 3
L-Menthol Injection as a Novel Technique During Colonoscopy
A Phase 3 study, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 82
- Enrollment target
NCT02588248 is a Phase 3 study that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 82 participants.
The verdict
NCT02588248, a Phase 3 study, was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 82 participants
- Enrollment target
Study Summary
The primary objective of this double-blinded, prospective, randomized placebo-controlled study is to evaluate for change in endoscopic adenoma detection rates (ADR) with the use of peppermint oil solution vs placebo application during colonoscopy. The investigators hypothesize that ADR will be increased with the use of the peppermint oil solution and thus further reduce the risk of colon cancer by means of colonoscopy.
Interventions
- OTHER Placebo
- DRUG Peppermint Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2017-04-27 |
| Est. Completion | 2017-05-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02588248
The ClinicalTrials.gov registry entry for NCT02588248 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02588248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02588248 about?
NCT02588248 is a clinical study titled "L-Menthol Injection as a Novel Technique During Colonoscopy". The primary objective of this double-blinded, prospective, randomized placebo-controlled study is to evaluate for change in endoscopic adenoma detection rates (ADR) with the use of peppermint oil solution vs placebo application during colonoscopy. The investigators hypothesize that ADR will be incre...
What is the current status of trial NCT02588248?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 82 participants. The study started on 2017-04-27. Estimated completion is 2017-05-30.
What interventions are being tested in trial NCT02588248?
The interventions under investigation include: Placebo (OTHER), Peppermint Oil (DRUG).
Who is sponsoring clinical trial NCT02588248?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.